Advisory Research Inc Axogen, Inc. Transaction History

Advisory Research Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$9.44 - $13.09 $231,053 - $320,390	-24,476 Reduced 28.11%	62,602 $624,000
Q3 2022 Nov 14, 2022	BUY	$8.14 - $12.25 $708,814 - $1.07 Million	87,078 New	87,078 $1.04 Million
Q2 2021 Aug 16, 2021	SELL	$17.8 - $23.5 $1.64 Million - $2.17 Million	-92,144 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$17.18 - $22.6 $1.14 Million - $1.49 Million	66,107 Added 253.9%	92,144 $1.87 Million
Q4 2020 Feb 12, 2021	BUY	$11.5 - $17.96 $299,425 - $467,624	26,037 New	26,037 $466,000
Q1 2019 May 15, 2019	SELL	$14.62 - $22.13 $363,219 - $549,797	-24,844 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$17.09 - $38.25 $236,149 - $528,538	-13,818 Reduced 35.74%	24,844 $508,000
Q3 2018 Nov 13, 2018	BUY	$34.05 - $55.9 $391,472 - $642,682	11,497 Added 42.32%	38,662 $1.43 Million
Q2 2018 Aug 14, 2018	BUY	$36.15 - $52.5 $982,014 - $1.43 Million	27,165 New	27,165 $1.37 Million

163

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $534M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

Stay updated on Advisory Research Inc with notifications on news.